Loading data for FENC — first visit, this takes a few seconds.
Fennec Pharmaceuticals In... (FENC)
NasdaqCM: FENC
· Real-Time Price · USD
11.29
-0.06 (-0.53%)
At close: Aug 21, 2026, 8:00 PM
11.25
-0.35%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Fennec Pharmaceuticals Inc. Common Stock (FENC) Stock Price, Analysis & Data
-0.53% (1D)
No data available
| Bid | 8.11 |
| Market Cap | 395.91M |
| Revenue (ttm) | 59.22M |
| Net Income (ttm) | -3.25M |
| 1.07 | |
| -0.12 | |
| n/a | |
| 11.86 | |
| P/B (ttm) | 9.32 |
| P/S (ttm) | 6.69 |
| Earnings Date | Nov 12, 2026 |
| Ask | 14.52 |
| Volume | 191,861 |
| Avg. Volume (20D) | 237,190 |
| Open | 11.47 |
| Previous Close | 11.35 |
| Day's Range | 11.22 - 11.65 |
| 52-Week Range | 5.65 - 13.25 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About FENC
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation,...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 15, 2017
Employees 35
Stock Exchange NasdaqCM
Ticker Symbol FENC
Website https://www.fennecpharma.com
Financial Performance
In 2025, Fennec Pharmaceuticals Common Stock's revenue was 44.64M, a decrease of -6.09% compared to the previous year's 47.54M. Earnings were -9.74M, an increase of 2,134.17%.
Financial StatementsEarnings Surprise
Fennec Pharmaceuticals Common Stock has released their quarterly earnings on Aug 11, 2026:
- Revenue of $15.11M misses estimates by $0, with 72.64% YoY growth.
- EPS of 0.05 exceeds estimates by 0.03, with 145.45% YoY growth.
Fennec Pharmaceuticals Inc. Common Stock is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2